Itchy skin, or pruritus, can be a symptom of liver disease. However, not everyone with liver disease experiences itching, and the specific causes of this itching are unknown. Treatment for itching ...

Prognosis of patients with type 2 refractory celiac disease is poor, there are no satisfactory treatments and transition to enteropathy-associated T-cell lymphoma is common. It is important that ...

Celiac disease (CD) is an immune-mediated enteropathy triggered by dietary gluten in genetically ... This underscores the need for pediatric gastroenterologists to extend their immunological ...

Kennedy’s plan to fight chronic disease, such as healthy school lunches and medical clinics that take a holistic approach to patient care. Now, the health secretary was strolling with the ...

Coeliac disease is an autoimmune condition where the body attacks its own tissues when gluten is eaten, which prevents normal digestion and absorption of food, with the risk of developing serious ...

In Singapore, “I see about five to 10 patients a year; some in my patients with Parkinson’s disease,” she said. Then, Dr Neo mentioned something that set off all kinds of alarm in my head: ...

‘A 17th-century pirate disease,’ Robbie told The Mirror. He added that he was getting incredibly thin, but his body dysmorphia made concerned comments from friends and family sound like ...

In the DE group, 43.1% of patients were refractory to at least 1 targeted therapy class. Nearly all patients in the DR group (96.7%) required additional therapy. Conversely, only 26.2% of patients ...

ALS drug effectively treats Alzheimer's disease in new animal study NU-9 acts on a common mechanism at play in both neurodegenerative diseases Date: April 8, 2025 Source: Northwestern University ...

The NSW Government has announced $180,000 in funding to increase access to treatment and support services for people living with macular disease. The one-off grant will support national charity ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that specifically target AChE and BChE linked to Alzheimer’s disease pathology.

Kennedy offered his own answer: “chronic disease,” to which “90 percent of health-care spending” is devoted. He specifically pointed to rising rates of obesity, diabetes, and cancer, as well as ...